Several excellent reviews have dealt with the issue of how TGF-β promotes EMT programs in late-stage carcinoma cells with some focussing on models of breast cancer [6–8] and pancreatic cancer [9, 10]. This evidence concerns the gene TGFB1 and pancreatic neoplasm.